Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Dec 24 | PVLA Palvella Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 13.6 | 24,700 | 335.92 k | 24,700 |
11 Jun 24 | VXRT Vaxart | Common Stock | Grant | Acquire A | No | No | 0 | 16,000 | 0.00 | 40,566 |
11 Jun 24 | VXRT Vaxart | Stock Option Common Stock | Grant | Acquire A | No | No | 0.77 | 95,400 | 73.46 k | 95,400 |
3 Jun 24 | BMRN BioMarin Pharmaceutical | Common Stock | Payment of exercise | Dispose F | No | No | 76.41 | 4,168 | 318.48 k | 97,720 |
3 Jun 24 | BMRN BioMarin Pharmaceutical | Common Stock | Option exercise | Acquire M | No | No | 63.1 | 5,047 | 318.47 k | 101,888 |
3 Jun 24 | BMRN BioMarin Pharmaceutical | Stock Option (Right to Buy Common Stock) Common Stock | Option exercise | Dispose M | No | No | 63.1 | 5,047 | 318.47 k | 0 |
21 May 24 | BMRN BioMarin Pharmaceutical | Common Stock | Grant | Acquire A | No | No | 0 | 4,720 | 0.00 | 96,841 |